dabigatran has been researched along with bms-262084 in 1 studies
| Studies (dabigatran) | Trials (dabigatran) | Recent Studies (post-2010) (dabigatran) | Studies (bms-262084) | Trials (bms-262084) | Recent Studies (post-2010) (bms-262084) |
|---|---|---|---|---|---|
| 3,887 | 261 | 3,490 | 12 | 0 | 3 |
| Protein | Taxonomy | dabigatran (IC50) | bms-262084 (IC50) |
|---|---|---|---|
| Urokinase-type plasminogen activator | Homo sapiens (human) | 0.135 | |
| Cationic trypsin | Bos taurus (cattle) | 0.072 | |
| Coagulation factor XI | Homo sapiens (human) | 0.0028 | |
| Trypsin-1 | Homo sapiens (human) | 0.0273 | |
| Trypsin-2 | Homo sapiens (human) | 0.05 | |
| Trypsin-3 | Homo sapiens (human) | 0.05 | |
| Plasminogen | Rattus norvegicus (Norway rat) | 0.43 | |
| Tryptase alpha/beta-1 | Homo sapiens (human) | 0.0042 | |
| Tryptase delta | Homo sapiens (human) | 0.0042 | |
| Tryptase gamma | Homo sapiens (human) | 0.0042 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jiang, X; Wong, PC | 1 |
1 other study(ies) available for dabigatran and bms-262084
| Article | Year |
|---|---|
Apixaban, a direct factor Xa inhibitor, inhibits tissue-factor induced human platelet aggregation in vitro: comparison with direct inhibitors of factor VIIa, XIa and thrombin.
Topics: Adenosine Diphosphate; Anticoagulants; Arginine; Azetidines; Benzimidazoles; Collagen; Dabigatran; Dose-Response Relationship, Drug; Factor VIIa; Factor Xa; Factor Xa Inhibitors; Factor XIa; Humans; Morpholines; Pipecolic Acids; Piperazines; Platelet Aggregation; Platelet Aggregation Inhibitors; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Sulfonamides; Thiophenes; Thrombin; Thromboplastin; Time Factors | 2010 |